The article above is Jonathan Broomberg’s (CEO Discovery Health) view of why medical scheme contributions are increasing year-on-year at a rate well above general price inflation. This is part of the current public hearings phase of the Competition Commission inquiry into the level of contributions and the sustained high increases therein year-on-year.
But this is just one view, and is that of a medical scheme. The Board of Healthcare Funders, the BHF, which is a lobby group for medical schemes and their administrators places the blame at the doors of private hospitals and specialists:
But what about the amounts schemes pay to their administrators or managed care organisations (who operate on a for-profit basis)?
What about the role of anti-selection given that medical scheme membership is voluntary and there are restrictions to underwriting, minimum benefits, etc.?
Join the debate!